Medical Licensing (MD/DO) · Independent exam preparation
DNB Final Examination in General Surgery: Decision-Based Preparation Guide Study Guide
Practise resuscitation, perioperative assessment, elective cancer pathways, operative decisions and evidence appraisal across all four DNB General Surgery papers.
By CertMedbry · Updated 18 October 2026
Learn to recognise threatened organs, assess operative risk, choose investigations that change management, plan safe tissue diagnosis and explain the science behind surgical decisions. These 60 selected concepts connect clinical reasoning with short-note writing and practical discussion across Paper 1, Paper 2, Paper 3 and Paper 4. The official NBEMS General Surgery curriculum defines the full scope, including knowledge and operative competencies beyond this selective guide. The selection does not imply official disease-level examination weights.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which qualification and pathway does this guide cover?
It covers the DNB Final Examination in General Surgery, a postgraduate broad-specialty exit examination conducted by the National Board of Examinations in Medical Sciences in India. The selected pathway is the registered DNB General Surgery trainee pathway. The expanded name Diplomate of National Board describes the qualification; it does not identify a separate examination. DrNB super-specialty examinations are separate.
NBEMS curriculum index · DNB Final Examination June 2026 Information Bulletin
How do other entry routes relate to this examination?
The June 2026 broad-specialty bulletin also describes an MD/MS-qualified route into the same broad specialty and applications for practical-only attempts after qualifying theory. These are eligibility or examination-stage differences, not separate General Surgery syllabuses. This guide does not determine eligibility for any route; the applicable session bulletin governs training, qualification, thesis and documentation requirements.
Which outline applies, and does it have an effective date?
The outline is the undated, 49-page Guidelines for Competency Based Training Programme in DNB General Surgery linked from the official NBEMS curriculum index and verified on 18 October 2026. Page 46 supplies the four-paper distribution. No curriculum revision number or effective date is stated. The June 2026 bulletin filename identifies 23.04.2026-V1; that date is not a curriculum effective date.
NBEMS curriculum index · Guidelines for Competency Based Training Programme in DNB General Surgery · DNB Final Examination June 2026 Information Bulletin
How are the four theory papers weighted?
Each paper carries 100 of the 400 theory marks, giving a derived weighting of 25% per paper. Topic-level percentages are not stated. Paper 1 covers applied sciences, surgical principles, perioperative care, trauma, critical care and research. Paper 2 covers elective orthopedics, skin and soft tissue, head and neck, breast and endocrine surgery. Paper 3 covers vascular and abdominal surgery. Paper 4 covers genitourinary and other subspecialties, transplantation and recent advances. This guide allocates 15 concepts, five questions and five flashcards to each paper; these equal counts do not represent official subject-level weights.
Guidelines for Competency Based Training Programme in DNB General Surgery · DNB Final Examination June 2026 Information Bulletin
How many questions are there, and are any pretest questions?
The June 2026 bulletin describes 10 short notes of 10 marks in each theory paper, while expressly allowing variation in the number of notes and their marks in some subjects or papers. It does not specify an operational-versus-pretest question split. These are written short-note papers, so a scored/pretest MCQ-bank model should not be assumed.
What duration, delivery and adaptivity are verified?
The June 2026 bulletin allows three hours for each of four theory papers and places the examination at designated centres. It describes written short-note assessment and does not describe adaptive item selection. The supplied material does not establish a computer-versus-paper response interface or a single standard duration for practical assessment. The 20 MCQs here are independent study exercises.
What follows theory, and what qualifying marks are documented?
Eligible candidates who qualify theory proceed to practical assessment. The June 2026 bulletin describes OSCE and/or clinical examination, together with viva. It specifies an aggregate theory qualifying requirement of 200/400 and a practical requirement of 150/300, with separate provisions governing theory rounding and grace marks. These historical session rules should not be treated as a complete statement of a later session's regulations. This learning test does not predict passing.
Does the June 2026 bulletin establish December 2026 arrangements?
No. It is a historical June 2026 session bulletin that corroborates examination identity and structure. It does not establish December 2026 application dates, fees, eligibility cut-offs, venues or amendments. Use the bulletin and corrigenda issued for the session you intend to enter. The official curriculum remains the full study scope; these 60 concepts are a selective learning aid.
DNB Final Examination June 2026 Information Bulletin · Guidelines for Competency Based Training Programme in DNB General Surgery
An independent preparation resource for India's NBEMS postgraduate DNB General Surgery broad-specialty exit examination, focused on the DNB trainee pathway. The MCQs are original learning drills; written theory and practical performance require separate preparation. Clinical recommendations are supported by the cited clinical guidance; the NBEMS curriculum establishes examination scope rather than prescribing those recommendations.
Outline used: Verified on 2026-10-09 using the undated, 49-page DNB General Surgery competency curriculum linked from NBEMS's official curriculum index. No curriculum revision number or effective date is stated. The June 2026 information bulletin, whose filename identifies 23.04.2026-V1, corroborates examination identity and structure; it is a historical session bulletin, not a December 2026 administrative handbook. The workbook label maps to the official DNB Final Examination in the General Surgery broad specialty; the assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Paper 125% of theory marks, derived from 100/400; topic weights not stated
1.How does vitamin C support wound strength?
Vitamin C supports collagen biosynthesis, including hydroxylation reactions needed for normal connective tissue. Deficiency therefore weakens tissue integrity and can produce poor wound healing, gingival bleeding and perifollicular haemorrhage. In a surgical patient with restricted intake, these associated findings distinguish a collagen problem from an isolated coagulation-factor disorder. The decision is to recognise and correct a nutritional deficiency while also evaluating mechanical, infective and perfusion causes of wound failure.
Apply it
A patient eating almost no fruit or vegetables develops friable wound edges, bleeding gums and perifollicular bruising. Explain how deficient collagen formation links these findings, then assess dietary intake alongside the wound's perfusion and infection status.
Common pitfall: Choosing vitamin K solely because bleeding is present misses the connective-tissue pattern. Vitamin C deficiency impairs collagen; several independent processes can still coexist in wound failure.
NIH Office of Dietary Supplements: Vitamin C, Health Professional Fact Sheet
2.Why does vitamin K deficiency impair haemostasis?
Vitamin K acts as a cofactor for carboxylation of specific glutamate residues in proteins, including several coagulation proteins. This modification enables their normal calcium-dependent function. Deficiency can therefore impair haemostasis without primarily disrupting collagen production. In perioperative assessment, distinguish a coagulation mechanism from vascular fragility and review nutrition, malabsorption and anticoagulant exposure. The clinical pattern and coagulation investigations guide interpretation; the presence of bruising alone does not identify the deficient vitamin.
Apply it
A patient with prolonged fat malabsorption develops abnormal coagulation tests before surgery. Describe why impaired vitamin K availability can reduce functional coagulation proteins, and contrast that mechanism with the connective-tissue abnormalities associated with vitamin C deficiency.
Common pitfall: Treating every bleeding manifestation as defective collagen ignores coagulation biology. Conversely, an abnormal coagulation test does not establish vitamin K deficiency without considering competing causes.
NIH Office of Dietary Supplements: Vitamin K, Health Professional Fact Sheet
3.When does sepsis require procedural source control?
Source control removes or contains an anatomical focus that continues to drive infection, such as an abscess, infected obstructed system or perforated viscus. Antimicrobials cannot reliably substitute for draining pus or correcting ongoing contamination. Identify whether a source requires intervention and coordinate it promptly with resuscitation and antimicrobial treatment. Obtain useful microbiological samples without harmful treatment delay. Choose the effective approach with the least physiological burden that can achieve control, recognising when percutaneous drainage is inadequate and operative treatment is necessary.
Apply it
After colorectal surgery, a patient becomes hypotensive and CT shows a drainable pelvic collection. Explain why escalating antibiotics alone is insufficient, and organise drainage while continuing haemodynamic support, cultures and antimicrobial treatment appropriate to the suspected infection.
Common pitfall: Waiting for every physiological abnormality to normalise before addressing an uncontrolled source can perpetuate shock. Resuscitation, antimicrobial treatment and effective source control usually need to proceed together.
4.How should fluid responsiveness and lactate guide sepsis resuscitation?
Fluid responsiveness means that increasing preload produces a meaningful increase in stroke volume or cardiac output. Dynamic assessment, such as passive leg raising with measured haemodynamic response, is more informative than isolated blood pressure or filling pressure. Additional fluid also requires inadequate perfusion and acceptable fluid tolerance. Serial lactate helps assess trajectory but can reflect altered metabolism or clearance as well as hypoperfusion. Persistent hypotension without fluid responsiveness favours reassessing vascular tone and cardiac function, with vasopressor support when indicated, rather than chasing lactate with repeated boluses.
Apply it
A postoperative patient remains hypotensive after initial fluids. Passive leg raising produces no meaningful stroke-volume increase, and lung congestion is emerging. Reassess perfusion, cardiac function and vascular tone; do not use persistent lactate elevation alone to justify more volume.
Common pitfall: Fluid responsiveness is not synonymous with a requirement for fluid. A falling lactate also does not establish complete source control or eliminate the need for clinical reassessment.
5.How should perioperative assessment distinguish a modifiable risk from a reason to delay surgery?
Assess procedural urgency and physiological stress alongside functional capacity, frailty, nutritional state, anaemia, cardiopulmonary disease, renal function and medication exposure. New chest pain, decompensated heart failure or an unstable arrhythmia requires evaluation before elective surgery; stable chronic disease instead requires an appropriate optimisation and monitoring plan. Select investigations to answer a clinical question that could change management. Emergency surgery may need to proceed with simultaneous resuscitation and risk mitigation because delaying definitive treatment can be more dangerous than the operative risk. The cardiovascular recommendations are clinical guidance supported by the [2024 AHA/ACC perioperative cardiovascular guideline](https://www.jacc.org/doi/10.1016/j.jacc.2024.06.013).
Apply it
Before elective colectomy, a patient reports new orthopnoea and reduced exercise tolerance. Assess possible decompensated cardiac disease and optimise it before proceeding, rather than treating these symptoms as an expected consequence of age.
Common pitfall: A normal routine test panel does not establish fitness for surgery. A risk classification describes risk but does not replace assessment of active disease, procedural urgency and postoperative support needs.
Guidelines for Competency Based Training Programme in DNB General Surgery
6.Why does haemorrhagic shock require haemostasis and blood-based resuscitation?
Blood loss reduces venous return, cardiac output and oxygen delivery. Compensatory vasoconstriction can preserve blood pressure despite clinically important hypoperfusion, so assess mental state, skin perfusion, pulse, urine output and serial metabolic findings. Control external bleeding immediately and identify internal haemorrhage requiring surgery or interventional treatment. Major ongoing bleeding requires activation of an appropriate major-haemorrhage protocol, with blood components, warming and monitoring of coagulation, fibrinogen and ionised calcium. Large crystalloid loads cannot replace oxygen-carrying capacity and can worsen dilution and hypothermia. These clinical management principles are supported by the [European trauma bleeding guideline, sixth edition](https://pmc.ncbi.nlm.nih.gov/articles/PMC9977110/).
Apply it
After pelvic trauma, a patient is pale, confused and tachycardic despite a temporarily acceptable blood pressure. Treat suspected ongoing haemorrhage, initiate appropriate blood support and organise definitive bleeding control rather than waiting for hypotension or a low haemoglobin result.
Common pitfall: Early haemoglobin can remain near baseline before fluid redistribution. Vasopressors or transient blood-pressure improvement do not correct ongoing blood loss, and associated brain injury changes perfusion priorities.
Guidelines for Competency Based Training Programme in DNB General Surgery · Trauma Service : Primary and secondary survey
7.What takes priority before CT in severe head injury?
Secondary brain injury can result from hypoxia and inadequate perfusion after the initial traumatic event. Initial care therefore prioritises airway, ventilation and circulation while protecting the cervical spine. CT defines intracranial pathology, but an unstable child should first receive the interventions required for safe transfer and imaging. A depressed level of consciousness increases concern about airway protection. The discriminating decision is whether the patient can safely reach and tolerate the scanner without preventable physiological deterioration.
Apply it
A child with head trauma has declining consciousness, noisy breathing and hypoxaemia. Stabilise the airway and oxygenation with cervical-spine precautions, address circulation, and arrange urgent imaging once the child can be transported safely with appropriate monitoring.
Common pitfall: Sending an inadequately oxygenated patient directly to CT prioritises diagnosis over prevention of secondary injury. Stabilisation should support urgent imaging, not become an excuse for avoidable delay.
8.How does neurological reassessment detect evolving head injury?
Head injury is dynamic: an initially reassuring assessment may precede expansion of an intracranial lesion or physiological deterioration. Repeated documentation of consciousness, pupils and focal neurological findings allows changes to be recognised and communicated. Compare findings with the patient's baseline and account for sedation, hypoxia and shock. New deterioration requires immediate reassessment of airway and circulation together with urgent escalation for intracranial evaluation; a previous normal examination cannot establish continuing safety in a changing patient.
Apply it
An observed child becomes harder to rouse and develops unequal pupils after an earlier stable examination. Repeat the primary assessment, document the neurological change and escalate urgently rather than attributing the change to sleep or relying on earlier observations.
Common pitfall: Recording a neurological score without its trend loses important information. Sedation can confound examination, but it should not automatically explain a new focal sign or unexpected decline.
9.How do the three surgical checklist pauses prevent harm?
The WHO checklist places structured checks before induction, before skin incision and before the patient leaves the operating room. Each pause addresses risks at the point when the team can still act: identity and anaesthetic hazards before induction, shared operative planning before incision, and counts, specimens and recovery concerns before departure. The mechanism is reliable team communication and verification. Completion should represent an active spoken process with relevant team participation, rather than retrospective documentation alone.
Apply it
During an operating-list review, the team discovers that specimen labelling and recovery concerns are discussed inconsistently. Map these tasks to sign out, while preserving the distinct identity, anaesthetic and pre-incision checks at their appropriate earlier pauses.
Common pitfall: A signed checklist does not demonstrate that the team communicated. Combining every check into one early pause misses hazards that arise or become assessable later in the operation.
10.When should prophylactic antibiotic administration be confirmed?
Surgical prophylaxis aims to establish appropriate antimicrobial exposure when operative contamination can occur. The WHO pre-incision pause asks whether indicated prophylactic antibiotics have been administered within the preceding 60 minutes, with suitability and exceptions considered locally. This is a verification of administration, not merely a prescription check. If prophylaxis is indicated but omitted, resolve the omission before incision when feasible. Therapeutic antibiotics for established infection require a separate clinical assessment of coverage and timing.
Apply it
Before incision for an operation requiring prophylaxis, the antibiotic appears on the chart but administration is undocumented. Ask the responsible clinician to verify actual delivery and resolve the uncertainty before proceeding, rather than assuming that prescribing ensured tissue exposure.
Common pitfall: Confusing an antibiotic order with completed administration defeats the check. The checklist's timing question also does not replace agent-specific considerations or a therapeutic plan for established infection.
11.How do allocation concealment and assessor blinding prevent different biases?
Allocation concealment prevents recruiters from knowing the upcoming assignment before enrolment is irreversible, reducing selection according to prognosis. A random sequence remains vulnerable if it can be inspected or predicted. Assessor blinding operates after assignment: it reduces the influence of treatment knowledge on measurement or interpretation, especially for subjective outcomes. Surgical teams may be impossible to blind while independent assessors remain feasible. Appraise the actual allocation mechanism, blinded roles and outcome susceptibility rather than relying on labels such as randomised or double-blind.
Apply it
A trial uses central allocation after enrolment and an independent examiner unaware of treatment to assess recurrence. Explain how the first arrangement protects recruitment and the second protects outcome assessment.
Common pitfall: Blinded assessment cannot repair manipulated enrolment. Conversely, inability to blind the operating surgeon does not prevent secure allocation or independent blinded assessment.
Cochrane Handbook, Chapter 8: Assessing risk of bias in a randomized trial
12.How should perioperative transfusion decisions balance oxygen delivery and transfusion hazards?
Red-cell transfusion increases oxygen-carrying capacity; it does not directly replace platelets or coagulation factors. The [2023 AABB guideline](https://doi.org/10.1001/jama.2023.12914) recommends a restrictive strategy, considering transfusion below haemoglobin 7 g/dL in haemodynamically stable hospitalised adults. Selected thresholds include 7.5 g/dL for cardiac surgery and 8 g/dL for orthopaedic surgery or pre-existing cardiovascular disease. Symptoms, comorbidity and clinical context remain relevant; these values are consideration thresholds, not automatic transfusion orders. Treat reversible causes such as iron deficiency. Do not apply these thresholds mechanically to active major haemorrhage or acute myocardial infarction. Verify patient and component identity and monitor for reactions. New fever, rigors, back pain, dyspnoea or hypotension during transfusion requires stopping the transfusion, maintaining venous access and urgent clinical and blood-bank assessment.
Apply it
A stable hospitalised adult awaiting abdominal surgery has iron-deficiency anaemia, haemoglobin 7.8 g/dL, no cardiovascular disease, no active bleeding, and no dyspnoea, chest pain or other symptoms attributable to anaemia. Routine transfusion is not indicated solely by this value; treat the deficiency and assess operative timing. If haemoglobin is 6.8 g/dL, consider red-cell transfusion under the restrictive strategy while assessing symptoms and context. Contrast both cases with active haemorrhage and deteriorating perfusion, where an early haemoglobin may remain misleadingly reassuring.
Common pitfall: A haemoglobin threshold supports a decision rather than replacing clinical assessment. Stable-anaemia thresholds should not delay treatment of major haemorrhage or be transferred mechanically to acute myocardial infarction.
Guidelines for Competency Based Training Programme in DNB General Surgery
13.How are absolute treatment benefit and NNT calculated and applied?
For an undesirable binary outcome, absolute risk reduction is control risk minus intervention risk. NNT is the reciprocal of that difference expressed as a proportion. A reduction from 12% to 8% gives an absolute reduction of 0.04 and an NNT of 25. Baseline risk matters: the same risk ratio of 0.5 gives NNTs of 10 for risks falling from 20% to 10%, and 100 for risks falling from 2% to 1%. State the outcome, population and follow-up period.
Apply it
In a 90-day surgical trial, complications occur in 60 of 500 controls and 40 of 500 treated patients. Calculate risks of 12% and 8%, a four-percentage-point absolute reduction and an NNT of 25, then assess applicability to the intended patient group.
Common pitfall: Use 0.04, not 4, in the reciprocal. A relative risk reduction cannot replace the absolute difference, and a trial's NNT should not be transferred unchanged to a different baseline risk.
Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
14.How should surgical thromboprophylaxis balance thrombosis and bleeding risk?
Assess venous thromboembolism risk from the procedure and patient factors, including cancer, previous thrombosis, immobility and obesity, alongside active bleeding and haemostatic abnormalities. Use suitable mechanical prophylaxis when anticoagulant prophylaxis is temporarily unsafe and reassess as haemostasis changes. For abdominal surgery, NICE NG89 recommends adding LMWH or fondaparinux for at least seven days when thrombosis risk outweighs bleeding risk, and considering extension to 28 postoperative days after major abdominal cancer surgery, including treatment after discharge. Check renal function: drug accumulation can require dose adjustment or another agent; NICE allows LMWH or UFH in renal impairment. Coordinate anticoagulant dosing with neuraxial insertion and catheter removal to minimise epidural haematoma risk, using the drug's specific timing requirements. These are clinical guidance recommendations rather than NBEMS examination rules.
Apply it
After major abdominal cancer surgery, an immobile patient initially has operative-site bleeding. Use appropriate mechanical prophylaxis while controlling bleeding. Once haemostasis is secure and thrombosis risk outweighs bleeding risk, add LMWH after checking renal function and neuraxial catheter timing. Provide at least seven days of pharmacological prophylaxis and consider a total of 28 postoperative days; if discharged earlier, arrange administration, education and completion at home.
Common pitfall: Early mobilisation may be insufficient for a high-risk patient, and discharge does not automatically end prophylaxis. Reassess temporary bleeding contraindications; avoid giving anticoagulants without accounting for renal function and neuraxial procedures.
Guidelines for Competency Based Training Programme in DNB General Surgery · Recommendations | Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism | Guidance | NICE
15.When can missing outcome data bias a trial?
Missing outcomes can bias a treatment estimate when the chance of an outcome being unobserved is related to its true value and differs in a way that distorts the comparison. The percentage missing alone does not settle the issue. Examine reasons, distribution between groups and plausible outcomes among missing participants. A surgical trial that loses patients with severe complications may appear safer than it is, even if the analysis includes all available observations correctly.
Apply it
A recovery trial loses contact with patients who required readmission elsewhere, especially in one treatment group. Explain why apparently favourable recovery scores among those remaining may be biased, and examine reasons for missingness and relevant sensitivity analyses.
Common pitfall: Equal numbers lost from each group do not guarantee unbiased results. Reasons and likely outcomes matter; describing an analysis as intention-to-treat does not recreate unobserved outcome measurements.
Cochrane Handbook, Chapter 8: Assessing risk of bias in a randomized trial
Paper 225% of theory marks, derived from 100/400; topic weights not stated
16.Which findings localise symptoms to the carpal tunnel?
Carpal tunnel syndrome results from compression of the median nerve at the wrist. Numbness or tingling affecting the thumb, index, middle and radial portion of the ring finger, often worse at night, supports this localisation. Advanced disease may produce thenar weakness or wasting. The distribution helps distinguish median neuropathy from ulnar neuropathy or more proximal neurological disease. Examination and, when appropriate, electrodiagnostic testing should connect the sensory pattern, motor findings and severity before treatment decisions.
Apply it
A patient wakes with tingling in the thumb, index and middle fingers and reports dropping small objects. Examine thenar function and the sensory distribution, then distinguish a wrist-level median neuropathy from symptoms centred on the little finger.
Common pitfall: Labelling all hand numbness as carpal tunnel syndrome ignores localisation. Little-finger symptoms, proximal findings or an atypical distribution should prompt consideration of a different or additional disorder.
American Academy of Orthopaedic Surgeons: Carpal Tunnel Syndrome
17.When does carpal tunnel release become appropriate?
Carpal tunnel release divides the transverse carpal ligament to reduce pressure on the median nerve. Surgery becomes a consideration when appropriate nonsurgical treatment has not controlled symptoms or when severe nerve dysfunction, weakness or muscle wasting raises concern about continuing damage. The decision depends on severity and functional impact, not symptom duration alone. Explain that decompression addresses the compressive mechanism, while recovery may be incomplete when longstanding nerve injury has already caused substantial loss of function.
Apply it
A patient has persistent median-distribution symptoms despite splinting, with progressive thenar wasting and impaired pinch. Discuss surgical decompression and realistic recovery expectations rather than repeatedly extending conservative treatment without reassessing evidence of severe nerve injury.
Common pitfall: Assuming that further splinting will reverse established muscle wasting can delay appropriate assessment. Successful release relieves compression but cannot guarantee complete recovery from advanced nerve damage.
American Academy of Orthopaedic Surgeons: Carpal Tunnel Syndrome
18.When does a thyroid nodule need functional scanning?
Thyroid-stimulating hormone helps distinguish a structural nodule problem from autonomous hormone production. A low TSH supports radionuclide scanning to determine whether a nodule is hyperfunctioning. A concordant hot nodule is rarely malignant and is assessed differently from a nonfunctioning nodule selected for biopsy by ultrasound features and size. Normal thyroid hormone tests do not exclude thyroid cancer. Functional status and structural malignancy risk answer different questions and should be interpreted together rather than interchangeably.
Apply it
A patient has a solitary thyroid nodule and suppressed TSH. Arrange functional assessment to determine whether the nodule is autonomous, while using ultrasound to relate its location and structural features to the rest of the gland.
Common pitfall: A normal TSH does not certify a nodule as benign. Conversely, sending every suppressed-TSH nodule directly for cytology bypasses information that functional scanning can provide.
19.How does ATA 2015 ultrasound risk guide thyroid nodule biopsy?
ATA 2015 high suspicion includes a solid hypoechoic nodule, or the hypoechoic solid component of a partially cystic nodule, with irregular margins, microcalcifications, taller-than-wide shape, extrathyroidal extension or disrupted rim calcification with extrusive soft tissue. Intermediate suspicion is a smooth hypoechoic solid nodule without microcalcifications, extrathyroidal extension or taller-than-wide shape. Both patterns warrant FNA at at least 1 cm. Low suspicion means an isoechoic or hyperechoic solid nodule, or a partially cystic nodule with eccentric solid areas, without microcalcifications, irregular margins, extrathyroidal extension or taller-than-wide shape; FNA is recommended at at least 1.5 cm. Very low suspicion means spongiform or partially cystic nodules lacking features of the low-, intermediate- and high-suspicion patterns. Consider FNA at at least 2 cm; observation is also reasonable. Pure cysts need no diagnostic FNA. Assess cervical nodes separately and sample suspicious nodes.
Apply it
A euthyroid adult's 1.6 cm partially cystic nodule with an eccentric isoechoic solid area and no suspicious features meets the low-suspicion FNA threshold. A 2.2 cm spongiform nodule lacking features of the other suspicion patterns permits observation or consideration of FNA. A 1.2 cm hypoechoic solid nodule with irregular margins warrants FNA.
Common pitfall: Partial cystic composition alone does not determine the biopsy threshold. Identify the solid component's arrangement, echogenicity and suspicious features before assigning the pattern. Do not mix ATA thresholds with another ultrasound scoring system, and do not let the primary nodule's size prevent separate evaluation of suspicious cervical nodes.
20.Why can follicular thyroid cytology remain indeterminate?
Fine-needle aspiration examines cells but cannot reliably demonstrate the capsular or vascular invasion needed to distinguish follicular carcinoma from follicular adenoma. A follicular-pattern result therefore describes a diagnostic limitation rather than proving either benignity or malignancy. Further assessment can include selected molecular testing or diagnostic surgery according to the overall findings. The key reasoning step is to identify what the test can establish and which architectural evidence requires examination of a larger tissue specimen.
Apply it
A thyroid aspirate is reported as a follicular neoplasm without unequivocal malignant cells. Explain why the absence of obvious cytological malignancy does not settle the diagnosis and why evaluation of invasion may require a surgical specimen.
Common pitfall: Calling an indeterminate aspirate benign because malignant cells were not seen overstates cytology. Repeating the same test may still fail to answer an architectural question.
21.Which biochemical tests investigate suspected pheochromocytoma?
Pheochromocytomas and sympathetic paragangliomas can produce catecholamines, causing episodic headache, sweating, palpitations and hypertension. Plasma free metanephrines or urinary fractionated metanephrines assess catecholamine metabolite excess and are central biochemical tests. The symptom pattern, an adrenal lesion or hereditary risk can raise suspicion. Imaging localises disease but does not by itself establish secretory status. Recognising possible catecholamine secretion before invasive manipulation matters because physiological stress can provoke dangerous haemodynamic instability.
Apply it
A patient with an adrenal mass reports episodic pounding headaches, sweating and palpitations. Investigate catecholamine excess with an appropriate metanephrine test before treating the lesion as an ordinary incidental mass suitable for unprepared invasive investigation.
Common pitfall: A radiological adrenal mass is not a biochemical diagnosis. Conversely, intermittent symptoms do not justify dismissing secretion merely because the patient is comfortable during examination.
22.Why must alpha blockade precede beta blockade?
Catecholamine excess stimulates alpha-mediated vasoconstriction and beta-mediated cardiac effects. In preoperative preparation for a functioning pheochromocytoma, establish appropriate alpha blockade before adding beta blockade when needed for tachycardia. Starting beta blockade first can leave alpha vasoconstriction unopposed and precipitate severe hypertension. Preparation also addresses volume contraction and haemodynamic monitoring. The sequence follows receptor physiology: controlling the pulse is insufficient when the dominant vascular hazard has not first been addressed during preparation.
Apply it
A patient awaiting adrenal surgery has biochemical catecholamine excess, hypertension and tachycardia. Explain why the preparation plan begins with alpha blockade and volume assessment, with beta blockade considered subsequently if clinically required for persistent tachycardia.
Common pitfall: Treating the fastest visible abnormality first can be dangerous here. A slower pulse after isolated beta blockade does not demonstrate safe control of catecholamine-driven vascular resistance.
23.How do breast cancer receptors change treatment?
Oestrogen and progesterone receptor expression identifies hormone-responsive biology and informs endocrine treatment. HER2 status identifies a different therapeutic target and can support HER2-directed treatment in appropriate disease settings. These biomarkers complement tumour stage, grade and patient factors; they do not substitute for anatomical staging. Two cancers with the same size and nodal status can therefore have different systemic treatment plans. Interpret the actual receptor results rather than treating every invasive breast cancer as biologically equivalent.
Apply it
Two patients have similarly sized invasive breast cancers, but their hormone receptor and HER2 profiles differ. Explain why the multidisciplinary systemic treatment discussion may differ even though their anatomical stage appears similar on initial assessment.
Common pitfall: Confusing receptor status with stage merges tumour biology and anatomical extent. Neither a favourable receptor profile nor a small primary tumour automatically removes the need for broader treatment assessment.
NCI: Breast Cancer Treatment PDQ, Health Professional Version
24.When can completion axillary dissection be omitted after a positive sentinel node?
Sentinel lymph node biopsy stages the first draining regional nodes with less morbidity than routine axillary dissection. Z0011 supports omission of completion dissection in a defined population: clinical T1–T2 invasive breast cancer, no palpable axillary adenopathy, one or two metastatic sentinel nodes, and upfront lumpectomy with negative margins, without preceding neoadjuvant systemic therapy. Patients must have no matted nodes or gross extranodal disease. Treatment includes tangential whole-breast radiotherapy and appropriate adjuvant systemic treatment. Within this treatment setting, omission did not compromise the trial's survival outcomes. Z0011 does not establish omission safety in patients with matted nodes, gross extranodal disease or positive lumpectomy margins.
Apply it
A patient with clinical T1 invasive breast cancer and no palpable axillary adenopathy undergoes upfront lumpectomy with negative margins, without neoadjuvant therapy. Two sentinel nodes contain metastases; there are no matted nodes or gross extranodal disease. Tangential whole-breast radiotherapy and appropriate adjuvant systemic treatment are planned. This illustrates the Z0011 omission setting. Finding matted nodes or macroscopically apparent tumour extending beyond a node would place the patient outside that trial's eligibility boundary, despite having only two positive sentinel nodes.
Common pitfall: Do not equate a positive sentinel node with either mandatory clearance or automatic omission. Check breast margins, tumour stage, clinical axillary findings, nodal burden, extranodal findings, treatment sequence and radiotherapy. Gross extranodal disease is macroscopically apparent tumour outside the node; microscopic extranodal extension is tumour beyond the nodal capsule identified histologically. These are distinct findings: the trial's gross-disease exclusion should not be relabelled as exclusion of every microscopic extension. However, Z0011 did not separately establish omission safety by the extent of microscopic extranodal extension. Mastectomy, greater nodal burden and residual nodal disease after neoadjuvant therapy also require evidence beyond Z0011.
NCI: Breast Cancer Treatment PDQ, Health Professional Version
25.Why is breast conservation usually linked to radiotherapy?
Breast-conserving treatment combines removal of the primary tumour with adequate margins and, usually, radiotherapy to address the risk of residual microscopic disease in the remaining breast. In appropriately selected early-stage disease, this approach can provide survival comparable with mastectomy. Selection considers disease extent, ability to achieve satisfactory margins, suitability for radiotherapy and patient preferences. Removing a small lump alone is not automatically equivalent to the complete breast-conserving treatment strategy evaluated in clinical studies.
Apply it
A patient with localised breast cancer prefers breast preservation but believes surgery eliminates the need for further local treatment. Explain the role of margins and radiotherapy, then discuss suitability using disease extent and the patient's treatment circumstances.
Common pitfall: Equating breast conservation with simple lump removal omits its integrated local-treatment components. Radiotherapy omission is a selected decision, not a general consequence of having a small tumour.
NCI: Breast Cancer Treatment PDQ, Health Professional Version
26.What does Breslow thickness measure in melanoma?
Breslow thickness is the vertical measurement in millimetres from the top of the epidermal granular layer to the deepest invasive melanoma cell. When the melanoma is ulcerated, measurement begins at the ulcer base. Thickness provides prognostic and staging information and contributes to decisions about excision margins and regional nodal assessment. Surface diameter cannot substitute for invasive depth. If the tumour is transected at the deep margin, the measured thickness is a minimum and the true maximum depth may remain undetermined.
Apply it
An ulcerated melanoma extends to the biopsy's deep margin. Identify the ulcer base as the measurement origin and explain why the reported depth cannot establish the tumour's complete maximum thickness.
Common pitfall: Measuring from the intact epidermal surface across an ulcer uses the wrong reference point. A deeply transected specimen must not be treated as a complete thickness assessment.
27.How does ulceration refine melanoma risk assessment?
Histological ulceration is an adverse feature that contributes to melanoma T categorisation alongside Breslow thickness. It reflects loss of the overlying epidermis with characteristic pathological changes, rather than simply a patient's report that a lesion once bled. Consequently, equal-thickness melanomas may occupy different risk categories when ulceration differs. Management decisions should use the pathology report and the full stage, including regional and distant disease assessment where indicated, rather than thickness as an isolated descriptor.
Apply it
Two invasive melanomas have identical measured thickness, but only one has histological ulceration. Explain why they should not automatically receive the same T subcategory and why clinical bleeding alone cannot establish the pathological feature.
Common pitfall: Calling any scratched or bleeding mole ulcerated can misclassify risk. Histological ulceration and Breslow thickness are complementary features, and neither alone establishes the complete disease stage.
28.Why should a suspicious soft-tissue mass be imaged before biopsy?
Local imaging defines a soft-tissue tumour's extent, depth and relationship to compartments, vessels and nerves. MRI is particularly useful for many suspicious extremity and trunk lesions and helps plan representative biopsy and possible definitive surgery. Imaging before biopsy also avoids confusing post-biopsy change with original tumour anatomy. A deep or enlarging mass requires an organised sarcoma pathway rather than casual excision, because an unplanned operation can compromise margins and complicate subsequent local treatment.
Apply it
A patient has an enlarging deep thigh mass near the neurovascular bundle. Arrange specialist local assessment and appropriate MRI before biopsy so the team can select a representative target and preserve options for definitive oncological surgery.
Common pitfall: Assuming that a painless mass is harmless can delay sarcoma assessment. Immediate removal without imaging may contaminate tissue planes and leave an inadequate or poorly planned excision.
British Sarcoma Group: UK guidelines for the management of soft tissue sarcomas
29.How should a sarcoma biopsy tract be planned?
A suspected soft-tissue sarcoma generally requires a planned core needle biopsy that obtains diagnostic tissue while preserving definitive treatment options. The tract should be positioned so it can be removed with the tumour during subsequent surgery and should avoid unnecessarily crossing uninvolved compartments or critical structures. Planning belongs with the specialist team that will manage the lesion. The goal is adequate histological diagnosis with minimal contamination, rather than the shortest skin-to-mass route regardless of future surgery.
Apply it
Imaging shows a suspicious thigh tumour. Before core biopsy, discuss the entry site and tract with the sarcoma team, ensuring that the planned definitive resection can encompass the tract without sacrificing avoidable uninvolved tissue compartments.
Common pitfall: A technically successful biopsy can still be oncologically poorly placed. Convenience, cosmetic location or proximity alone should not determine a tract that complicates subsequent tumour resection.
British Sarcoma Group: UK guidelines for the management of soft tissue sarcomas
30.When does an adult neck mass require malignancy assessment?
An adult neck mass without an infectious explanation that persists for at least two weeks without significant fluctuation, or has uncertain duration, raises concern for malignancy. Firmness, fixation, skin ulceration or size greater than 1.5 cm are additional suspicious features. Evaluation includes targeted head-and-neck examination, appropriate contrast imaging and fine-needle aspiration when diagnosis remains uncertain. A cystic appearance does not establish benignity. Continue evaluation until a diagnosis is secured rather than defaulting to antibiotics or open biopsy.
Apply it
An adult has a firm lateral neck mass for six weeks without fever or an infectious history. Arrange a malignancy-focused examination, appropriate imaging and fine-needle aspiration rather than prescribing another empirical antibiotic course or immediately performing open biopsy.
Common pitfall: A cystic lateral neck mass in an adult can be metastatic. Apparent cystic structure or a nondiagnostic initial sample should not prematurely terminate an appropriate malignancy work-up.
AAO-HNSF Clinical Practice Guideline: Evaluation of the Neck Mass in Adults, 2017
Paper 325% of theory marks, derived from 100/400; topic weights not stated
31.When is nonoperative care appropriate for adhesive obstruction?
Adhesive small bowel obstruction can often be managed initially with bowel rest, decompression when indicated, intravenous fluid and electrolyte correction, and close reassessment. This approach requires the absence of peritonitis, strangulation or bowel ischaemia. CT helps assess the cause and detect features that make delay unsafe. The decision is conditional rather than permanent: worsening pain, physiological deterioration or concerning imaging requires renewed operative assessment even if adhesions initially seemed the likely cause.
Apply it
A patient with previous laparotomy has vomiting and CT-confirmed small bowel obstruction but no peritonitis, ischaemic features or haemodynamic instability. Start monitored nonoperative treatment while defining the examination and imaging changes that would trigger urgent surgical reassessment.
Common pitfall: A history of adhesions does not exclude strangulation or another cause. Nonoperative treatment is a supervised strategy with reassessment, not permission to ignore evolving clinical deterioration.
WSES Bologna guidelines for adhesive small bowel obstruction: 2017 update
32.How does water-soluble contrast help assess obstruction?
In appropriately selected adhesive small bowel obstruction, progression of water-soluble contrast into the colon helps predict resolution with nonoperative management. Failure to reach the colon on the follow-up study at approximately 24 hours is strongly suggestive of nonoperative treatment failure. Transit is prognostic evidence; it neither proves that contrast caused recovery nor establishes clinical resolution or bowel viability. Continue assessment of pain, distension, vomiting, examination and physiological trajectory, and act on peritonitis, suspected strangulation or ischaemia regardless of contrast progression.
Apply it
A stable patient undergoing nonoperative treatment has contrast visible in the colon on the planned follow-up radiograph. Explain why this supports likely resolution, while continuing to monitor symptoms and examination before deciding that the obstruction has clinically settled.
Common pitfall: Waiting for a scheduled contrast image in a deteriorating patient can delay necessary surgery. Contrast progression predicts outcome; it does not certify bowel viability in every circumstance.
WSES Bologna guidelines for adhesive small bowel obstruction: 2017 update
33.When is CT angiography urgent in mesenteric ischaemia?
Acute mesenteric ischaemia should be considered when severe abdominal pain appears disproportionate to early examination findings, especially with embolic or vascular risk. Urgent CT angiography assesses mesenteric vessels and bowel changes and should not be postponed for reassuring routine laboratory results, including a normal lactate. Lactate lacks sufficient sensitivity to exclude early disease and can rise from other causes. Early examination can be relatively unimpressive before infarction causes peritonitis. Clinical suspicion should trigger vascular investigation before potentially reversible ischaemia becomes irreversible intestinal injury.
Apply it
A patient with atrial fibrillation develops sudden severe abdominal pain with initially modest tenderness. Arrange urgent CT angiography and surgical assessment despite an early normal lactate, rather than waiting for peritonitis or a rising biomarker to establish concern.
Common pitfall: A soft abdomen or normal lactate early in the illness does not exclude dangerous intestinal ischaemia. An elevated lactate also does not independently prove bowel infarction.
34.How does staging determine the elective colon cancer pathway?
Confirm the diagnosis histologically through colonoscopy and assess the remaining colon for synchronous lesions. Stage distant disease with appropriate cross-sectional imaging and obtain a baseline CEA for subsequent interpretation; CEA alone cannot diagnose or exclude cancer. For resectable nonmetastatic invasive colon cancer, plan oncological colectomy with its regional lymphatic drainage. Pathological depth, nodal status and margins then guide further treatment: regional nodal involvement defines stage III disease and supports adjuvant chemotherapy assessment. Metastatic disease requires a coordinated systemic and resectability assessment rather than an automatic assumption that primary resection is curative.
Apply it
Biopsy confirms a sigmoid adenocarcinoma without obstruction. Complete staging before elective surgery. After oncological resection, distinguish node-positive disease requiring adjuvant treatment assessment from a localised tumour whose further treatment depends on pathological risk.
Common pitfall: A technically removable primary does not establish absence of metastases. A normal CEA does not exclude cancer, and an operation without adequate regional nodal assessment can leave staging incomplete.
Guidelines for Competency Based Training Programme in DNB General Surgery · Colon Cancer Treatment (PDQ®) - NCI
35.What defines severe acute pancreatitis?
Persistent organ failure lasting more than 48 hours defines severe acute pancreatitis in the revised Atlanta framework discussed by WSES. Organ failure can involve respiratory, cardiovascular or renal systems. Transient organ failure or local complications without persistent organ failure belong to a different severity category. The distinction matters because physiological failure drives monitoring, support and prognosis. Neither a high enzyme concentration nor the mere presence of pancreatic necrosis independently establishes the severe category in this classification.
Apply it
One patient has pancreatic necrosis but no organ failure; another has respiratory failure persisting beyond 48 hours. Identify the second patient's severe disease category and explain why anatomy and physiological severity must be described separately.
Common pitfall: Equating every necrotising episode with severe pancreatitis confuses morphology with severity. The duration of organ failure is decisive; enzyme magnitude is not a substitute for physiological assessment.
2019 WSES guidelines for the management of severe acute pancreatitis
36.Which findings distinguish possible infected necrosis from sterile pancreatic inflammation?
Sterile pancreatic necrosis can cause fever, leukocytosis and organ dysfunction, so these findings alone do not establish infection and do not justify routine prophylactic antibiotics. New clinical deterioration or sepsis raises concern for infected necrosis or another infectious source. Gas within a necrotic collection supports infection, although its absence does not exclude it. Microbiological evidence, when available, strengthens diagnosis and guides treatment. Procalcitonin can support assessment but is not definitive in isolation. Suspected or established infection requires antimicrobial treatment and assessment of whether source control is needed.
Apply it
A patient initially improves after necrotising pancreatitis, then develops sepsis and new gas within a necrotic collection. Treat the pattern as strongly concerning for infection, obtain appropriate cultures and assess drainage. Contrast this with isolated fever and leukocytosis during otherwise improving sterile inflammation.
Common pitfall: Neither fever nor leukocytosis distinguishes sterile inflammation from infection. Absence of gas cannot rule infection out, and an elevated procalcitonin does not independently establish its site or cause.
Client Challenge · 2019 WSES guidelines for the management of severe acute pancreatitis
37.How do timing and a step-up strategy guide pancreatic necrosis intervention?
Walled-off necrosis usually develops after approximately four weeks. When clinically tolerable, defer intervention until the collection is organised; delayed necrosectomy is generally safer than early debridement. A step-up strategy begins with percutaneous or endoscopic drainage and escalates to necrosectomy if necessary. Deterioration with suspected infected necrosis may require earlier drainage before full wall maturation; drainage timing and necrosectomy timing are separate decisions. Other emergencies, such as bowel ischaemia, uncontrolled bleeding or abdominal compartment syndrome unresponsive to conservative measures, may require earlier intervention.
Apply it
At two weeks, a patient with suspected infected necrosis deteriorates despite antimicrobial and supportive treatment. Consider drainage for source control now, while seeking to defer necrosectomy until the necrosis has become better demarcated if the subsequent course permits.
Common pitfall: Four weeks is a maturation benchmark, not a requirement to leave uncontrolled deterioration untreated. Earlier drainage does not automatically require immediate open necrosectomy.
Client Challenge · 2019 WSES guidelines for the management of severe acute pancreatitis
38.Why does rectal cancer require local staging before definitive surgery?
After histological confirmation, assess tumour height, sphincter relationship and distant disease, and use pelvic MRI to define local depth, regional nodes and the relationship to the mesorectal fascia. A threatened circumferential resection margin or locally advanced disease can change treatment from immediate surgery to preoperative multimodality treatment followed by reassessment. ASCRS supports local excision for carefully selected cT1N0 cancers: typically under 3 cm, involving under 30% of the circumference, well or moderately differentiated, without lymphovascular invasion, perineural invasion or tumour budding, and accessible for adequate full-thickness excision. Local excision does not remove or pathologically stage mesorectal nodes. Adverse final pathology, including inadequate margins, deeper T stage, deep submucosal invasion, poor differentiation or those adverse histological features, generally requires completion radical resection because residual or occult nodal disease can remain despite a small primary. Radical rectal surgery uses mesorectal excision principles; sphincter preservation depends on oncological margins, anatomy and functional expectations.
Apply it
A biopsy-proven rectal cancer appears operable clinically, but MRI shows tumour approaching the mesorectal fascia. Discuss preoperative treatment in the multidisciplinary team because margin risk changes the sequence of care. In a separate cT1N0 case, a 2 cm moderately differentiated lesion involving 20% of the circumference and accessible for full-thickness excision may meet local-excision criteria if adverse features are absent. Lymphovascular invasion on the final specimen changes that assessment and supports completion radical resection.
Common pitfall: Small size alone does not establish suitability for local excision. Clinical N0 staging cannot eliminate occult nodal disease, and adverse final pathology can require radical resection even after apparently complete removal of a small primary.
Guidelines for Competency Based Training Programme in DNB General Surgery · Management of Rectal Cancer (2020) | Evidence-based Guidelines and Expert Consensus
39.When does an irreducible hernia require immediate surgery?
An incarcerated hernia is irreducible; a strangulated hernia additionally compromises the blood supply of its contents. Suspected intestinal strangulation requires immediate operative management because progressive ischaemia can cause necrosis, perforation and systemic illness. Increasing pain, tenderness, obstruction, skin change, systemic deterioration and concerning imaging strengthen suspicion. Do not require every feature to be present before acting. Resuscitation accompanies urgent surgical treatment rather than replacing it with prolonged observation of a potentially threatened bowel segment.
Apply it
A previously reducible groin hernia becomes painful and irreducible, with vomiting, marked tenderness and systemic deterioration. Treat the presentation as possible strangulation, begin resuscitation and arrange urgent surgery rather than observing solely for spontaneous reduction.
Common pitfall: Irreducibility and strangulation are not identical, but absence of skin discolouration does not exclude ischaemia. Forceful reduction can obscure a compromised bowel segment without resolving its injury.
2017 WSES guidelines for emergency repair of complicated abdominal wall hernias
40.Which findings indicate an immediately threatened limb?
In acute limb ischaemia, sensory loss beyond the toes with motor weakness indicates an immediately threatened, potentially salvageable limb, corresponding to category IIb. Urgent revascularisation is needed if salvage is to be achieved. Classification relies on neurological findings and Doppler signals as well as pain and appearance. A missing pulse alone does not distinguish a viable limb from one requiring immediate action. New weakness is especially important because it signals advanced impairment of muscle and nerve perfusion.
Apply it
A patient with sudden leg pain has absent arterial Doppler signals, sensory loss across the forefoot and new difficulty moving the toes. Explain why neurological dysfunction makes the situation more urgent than isolated pulselessness without sensory or motor loss.
Common pitfall: Waiting for complete paralysis before escalating misses a salvageable emergency. Motor weakness in acute ischaemia is a threat marker, not a routine symptom to investigate electively.
2024 AHA/ACC Lower Extremity Peripheral Artery Disease Guideline slide set
41.What distinguishes irreversible acute limb ischaemia?
Profound anaesthesia, paralysis and absent arterial and venous Doppler signals support category III acute limb ischaemia, in which major tissue loss or permanent nerve damage is inevitable. This differs from an immediately threatened but salvageable limb. Revascularising irreversibly damaged tissue can expose the patient to severe reperfusion consequences without restoring useful viability. The decision therefore requires urgent expert assessment of limb viability and the patient's overall condition, rather than assuming every occlusion should undergo attempted revascularisation.
Apply it
An acutely ischaemic limb is insensate and paralysed, with no arterial or venous Doppler signals. Distinguish this pattern from category IIb and explain why assessment of irreversible damage must precede an assumption that revascularisation will restore function.
Common pitfall: Classifying severity by symptom duration alone ignores the actual examination. Conversely, isolated absent arterial signals do not establish irreversibility without the neurological and other viability findings.
2024 AHA/ACC Lower Extremity Peripheral Artery Disease Guideline slide set
42.How should a noncompressible ankle-brachial index be investigated?
An ankle-brachial index above 1.40 suggests noncompressible ankle arteries and can be falsely reassuring, particularly in diabetes or chronic kidney disease. Calcified arteries resist cuff compression, so the measured ankle pressure may not reflect useful perfusion. Toe pressure and toe-brachial index with waveforms provide additional assessment because digital arteries are less commonly noncompressible. Interpret physiological testing alongside symptoms, wounds and examination. A high ankle value is a measurement limitation, not proof that arterial disease is absent.
Apply it
A patient with diabetes has a nonhealing toe wound and an ankle-brachial index of 1.52. Request toe-based physiological testing with waveforms rather than dismissing peripheral arterial disease because the ankle pressure appears high.
Common pitfall: Reading every high ankle-brachial index as excellent circulation overlooks medial arterial calcification. A normal-looking numerical result must still be reconciled with tissue loss and clinical findings.
2024 AHA/ACC Lower Extremity Peripheral Artery Disease Guideline slide set
43.Why is structured exercise central to claudication treatment?
Chronic symptomatic peripheral artery disease requires cardiovascular risk reduction and treatment of functional limitation. Structured exercise improves walking performance and quality of life and is a core therapy for claudication. Revascularisation can be considered for functionally limiting symptoms that respond inadequately to guideline-directed treatment, including structured exercise. The decision should connect the patient's goals, symptom burden and anatomy. An arterial stenosis on imaging alone does not establish that an intervention will provide worthwhile functional benefit.
Apply it
A patient has reproducible calf discomfort with walking but no rest pain or tissue loss. Discuss structured exercise and cardiovascular risk treatment, then assess persistent functional limitation before considering whether revascularisation would meaningfully improve daily activities.
Common pitfall: Treating an imaging lesion before assessing disability and conservative treatment can lead to unnecessary intervention. Claudication management also includes systemic cardiovascular risk, not only walking distance.
2024 AHA/ACC Lower Extremity Peripheral Artery Disease Guideline slide set
44.When does chronic limb-threatening ischaemia need limb-salvage assessment?
Chronic limb-threatening ischaemia combines objectively demonstrated arterial disease with chronic ischaemic rest pain, nonhealing wounds or gangrene. It differs from uncomplicated exertional claudication because tissue viability is threatened. Assessment integrates perfusion, wound extent, infection and the feasibility of revascularisation, while providing wound care and cardiovascular treatment. A multidisciplinary limb-salvage approach is important. Do not infer adequate perfusion from a palpable proximal pulse or a misleading ankle pressure when the distal tissue findings suggest an unresolved ischaemic problem.
Apply it
A patient has persistent forefoot rest pain and a nonhealing ulcer with abnormal toe perfusion. Arrange vascular limb-salvage assessment while addressing wound care and infection, rather than managing the presentation as ordinary exertional claudication.
Common pitfall: Local dressings alone cannot correct inadequate arterial inflow. Equally, not every chronic ulcer is ischaemic; objective perfusion assessment helps distinguish arterial disease from other causes.
2024 AHA/ACC Lower Extremity Peripheral Artery Disease Guideline slide set
45.What establishes the critical view of safety?
The critical view of safety during laparoscopic cholecystectomy requires clearance of the hepatocystic triangle, separation of the lower gallbladder from the liver to expose the cystic plate, and confirmation that only two structures enter the gallbladder. The purpose is reliable identification before division, reducing misidentification of major ducts or vessels. Seeing two tubular structures without the other criteria is insufficient. If the view cannot be achieved safely, the surgeon must reassess anatomy and the operative strategy.
Apply it
During cholecystectomy, two structures are visible but the lower gallbladder remains attached and the triangle is obscured. Explain why the critical view is incomplete and why clipping should wait for reliable identification or a safer alternative strategy.
Common pitfall: An apparent infundibular funnel can mislead in severe inflammation. Counting two structures alone does not establish all critical-view criteria or make division safe in uncertain anatomy.
SAGES: Safe Cholecystectomy Multi-Society Practice Guideline
Paper 425% of theory marks, derived from 100/400; topic weights not stated
46.Why is an infected obstructed kidney a drainage emergency?
An obstructed collecting system with infection can sustain sepsis because infected urine cannot drain effectively. Urgent decompression by ureteric stent or percutaneous nephrostomy provides source control, together with antimicrobial treatment and supportive care. Definitive stone removal is generally delayed until the infection has resolved. The immediate decision is to drain the infected system, not to prioritise stone clearance during uncontrolled sepsis. Obtain appropriate urine and blood cultures while avoiding harmful delay in treatment of the acutely ill patient.
Apply it
A patient has fever, hypotension and hydronephrosis above an obstructing ureteric stone. Arrange urgent urinary drainage and antimicrobial treatment, with definitive stone management planned after stabilisation and infection control rather than during the initial septic episode.
Common pitfall: Antibiotics alone may fail when infected urine remains obstructed. Conversely, proceeding directly to definitive stone fragmentation during uncontrolled infection can worsen the patient's physiological risk.
47.How should imaging be selected for suspected urinary stones?
Imaging for suspected stones should establish stone presence, location and obstruction while considering radiation and clinical urgency. Ultrasound is a useful initial modality; noncontrast CT provides more precise confirmation in appropriate acute presentations and can identify alternative diagnoses. Fever, a solitary kidney or diagnostic uncertainty increases the need for prompt assessment. Pregnancy changes the imaging balance, with ultrasound preferred initially. No imaging choice should delay necessary resuscitation or emergency treatment when infected obstruction is clinically suspected.
Apply it
A nonpregnant adult has persistent acute flank pain and an inconclusive ultrasound. Discuss noncontrast CT to clarify a possible ureteric stone and alternative pathology, while checking for infection, renal impairment and circumstances that make assessment urgent.
Common pitfall: Contrast-enhanced CT is not automatically required to identify a urinary stone. Equally, a negative or limited ultrasound does not reliably exclude a ureteric calculus in persistent symptoms.
48.When should suspected testicular torsion proceed to exploration?
Testicular torsion compromises the spermatic cord blood supply and threatens testicular viability. Sudden severe unilateral scrotal pain, associated nausea and an abnormal testicular lie support suspicion, but no single sign excludes it. When torsion cannot be confidently excluded, prompt surgical assessment and exploration are required. Ultrasound must not delay treatment in a clinically suspicious presentation. The decisive issue is time-sensitive ischaemia, rather than completing an imaging sequence before involving the surgeon responsible for definitive care.
Apply it
An adolescent develops sudden unilateral scrotal pain with vomiting and a high-lying testis. Arrange immediate surgical assessment and likely exploration rather than waiting for a delayed Doppler appointment to confirm an already concerning clinical presentation.
Common pitfall: Preserved flow on an imperfect study or incomplete classic signs can create false reassurance. Imaging is useful only when it can inform care without delaying necessary intervention.
49.Why must pyloric stenosis be corrected physiologically before surgery?
Repeated gastric losses in infantile pyloric stenosis can cause dehydration and hypochloraemic metabolic alkalosis, sometimes with potassium depletion. Pyloromyotomy corrects the obstruction, but anaesthesia should follow correction of dehydration and metabolic abnormalities. Persistent alkalosis is particularly relevant to respiratory risk. The characteristic presentation is progressive nonbilious vomiting in a young infant, although early laboratory findings may not yet be classic. The priority is physiological preparation followed by definitive surgery, rather than immediate operation on an unresuscitated infant.
Apply it
A young infant with ultrasound-confirmed pyloric stenosis has dehydration, low chloride and alkalosis. Begin appropriate fluid and electrolyte correction, monitor the biochemical response and coordinate surgery once physiological abnormalities have been adequately corrected for safe anaesthesia.
Common pitfall: Calling the condition surgical does not make immediate incision the first treatment. Absence of classic alkalosis early in the illness also does not exclude pyloric stenosis.
50.Which test confirms Hirschsprung disease?
Hirschsprung disease results from absence of enteric ganglion cells in affected distal bowel, producing functional obstruction. Rectal biopsy establishes the diagnosis by examining tissue for the characteristic absence of ganglion cells. Contrast enema and anorectal manometry can support assessment but do not replace histological confirmation. Delayed passage of meconium, distension and persistent constipation raise suspicion. The key distinction is between tests suggesting a transition or abnormal physiology and tissue assessment demonstrating the underlying enteric nervous system abnormality.
Apply it
An infant has abdominal distension, delayed meconium passage and persistent obstructive symptoms. Explain why a suggestive contrast study should lead to appropriate rectal biopsy rather than being treated as definitive proof of the underlying ganglion-cell disorder.
Common pitfall: A radiological transition zone is supportive rather than confirmatory. Sampling technique and site matter, so an inadequate specimen should not be interpreted as a reliable exclusion.
51.When is enema reduction appropriate for intussusception?
Enema reduction can treat suitable ileocolic intussusception without surgery, but it requires a resuscitated, clinically appropriate child and access to surgical support. Shock, peritonitis, perforation or an unstable clinical condition contraindicates the procedure. These findings suggest that pressurised reduction may be unsafe or that bowel injury requires operative management. The decision therefore follows assessment and stabilisation, not ultrasound confirmation alone. A child with contraindications needs urgent surgical management rather than repeated attempts to achieve radiological reduction.
Apply it
Ultrasound confirms ileocolic intussusception in a child with guarding, poor perfusion and persistent instability. Continue resuscitation and obtain urgent surgical management rather than sending the child directly for enema reduction because the diagnosis is established.
Common pitfall: A positive ultrasound identifies the condition but does not establish procedural suitability. Failure to assess perfusion and peritoneal signs can turn a useful treatment into an unsafe intervention.
52.How can intussusception present before bloody stool appears?
Intussusception can cause intermittent severe distress, pallor, vomiting or unexplained episodic lethargy. Children may appear relatively well between episodes, and diarrhoea can initially suggest gastroenteritis. Rectal bleeding is a later feature, so the classic combination of pain, palpable mass and bloody stool should not be required before investigation. Ultrasound is the preferred initial diagnostic examination in a suitable setting. Recognising the episodic pattern enables assessment before bowel compromise produces more obvious late signs and systemic deterioration.
Apply it
A toddler has repeated brief episodes of pallor and distress with normal behaviour between them, followed by vomiting. Consider intussusception and arrange ultrasound despite the absence of a palpable mass or blood in the stool.
Common pitfall: Waiting for red currant jelly stool delays diagnosis. An apparently comfortable interval or initial diarrhoea does not safely exclude an intermittent obstructive process such as intussusception.
53.What causes hyperacute transplant rejection?
Hyperacute rejection occurs when pre-existing recipient antibodies recognise donor antigens, often ABO or HLA targets, and rapidly injure graft endothelium. Complement activation and thrombosis can destroy perfusion soon after transplantation. This mechanism differs from a newly developed cellular response that takes time to evolve. Compatibility testing and crossmatching aim to identify important pre-existing incompatibility before implantation. The discriminating cues are the immediate timing, vascular injury and an antibody response already present in the recipient before the graft arrives.
Apply it
A graft loses perfusion almost immediately after implantation, with widespread vascular thrombosis. Explain why preformed recipient antibodies are a concern and relate the mechanism to the purpose of compatibility assessment and crossmatching before transplantation.
Common pitfall: Immediate graft dysfunction has surgical and nonimmune causes as well. Timing suggests hyperacute rejection, but vascular thrombosis alone should not be treated as definitive proof of its mechanism.
54.How does acute rejection differ from hyperacute rejection?
Acute rejection reflects an immune response against the graft that may involve recipient T cells, antibodies or both. It commonly emerges after the immediate implantation period and can also occur later, particularly when immunosuppression is inadequate. Hyperacute rejection instead depends on clinically important pre-existing antibodies causing rapid vascular injury. Timing helps frame the differential but does not establish the diagnosis alone. Graft dysfunction also requires assessment for technical problems, infection, drug toxicity and other organ-specific causes before assigning immune rejection.
Apply it
A renal transplant recipient develops deteriorating graft function after the early postoperative period. Consider acute rejection alongside obstruction, vascular problems, infection and drug effects, and explain why the timing differs from immediate antibody-mediated graft destruction.
Common pitfall: Assuming that every rise in a graft-function marker is rejection risks inappropriate treatment. Acute rejection can be cellular or antibody mediated, and late presentation does not exclude it.
55.Why does transplant immunosuppression create competing risks?
Immunosuppression reduces recipient immune attack on transplanted tissue but also weakens protective immune responses. This creates competing risks of rejection when suppression is inadequate and infection or malignancy when immune surveillance is impaired. The aim is an individually appropriate balance rather than maximal suppression at all times. Interpretation of new graft dysfunction or systemic illness must therefore consider both immune injury and treatment-related vulnerability. Intensifying immunosuppression without investigating infection can worsen a problem that resembles rejection clinically.
Apply it
A transplant recipient develops fever and worsening graft function. Explain why the team must investigate infection as well as rejection before simply increasing immunosuppression, and describe the opposing risks that make the treatment decision clinically important.
Common pitfall: More immunosuppression is not automatically better graft care. Conversely, reducing treatment indiscriminately during illness can expose the graft to rejection; the underlying cause must guide the balance.
56.Which immune system attacks in graft-versus-host disease?
Graft-versus-host disease occurs when immunocompetent donor immune cells recognise recipient tissues as foreign and attack them. The direction is donor against recipient, unlike conventional graft rejection in which recipient immunity attacks donor tissue. The distinction is particularly important in haematopoietic stem-cell transplantation, where donor lymphocytes are integral to the graft. Skin, gastrointestinal and liver involvement are characteristic clinical patterns. Naming the attacking and targeted compartments makes the mechanism clearer than memorising transplant terminology without its immune direction.
Apply it
After an allogeneic stem-cell transplant, a patient develops a rash, diarrhoea and liver abnormalities. Explain how donor immune cells can injure recipient tissues and contrast this direction with recipient-mediated rejection of a transplanted solid organ.
Common pitfall: Calling graft-versus-host disease ordinary organ rejection reverses the immune direction. A post-transplant rash or diarrhoea also has competing causes and does not independently establish this diagnosis.
57.How do HLA matching and crossmatching answer different questions?
HLA matching compares donor and recipient tissue antigens to assess immunological similarity. Crossmatching evaluates whether recipient antibodies react against donor cells or relevant donor antigens, addressing pre-existing sensitisation. These approaches are related but not interchangeable: a favourable antigen match does not by itself establish absence of clinically important donor-reactive antibodies. The distinction explains why transplant compatibility assessment uses more than one measure. Each test informs a different part of the risk of recipient immune injury to donor tissue.
Apply it
A transplant discussion describes a good HLA match but also a concerning antibody crossmatch. Explain why these findings are not contradictory and why antigen similarity alone cannot establish that the recipient lacks antibodies capable of reacting with the donor.
Common pitfall: Treating a good HLA match as a guarantee against rejection overstates matching. Crossmatch results address pre-existing reactivity, while later immune responses and nonimmune graft injury remain possible.
58.Who controls surgeon-controlled robotically assisted surgical systems?
Surgeon-controlled robotically assisted surgical systems are one type of computer-assisted surgical system; the broader category also includes surgical planning and navigation systems. In the robotically assisted subgroup described by the FDA, the device translates the surgeon's control inputs into instrument movement under direct human control. It assists visualisation and manipulation while the surgeon makes procedural decisions. Device-specific training, familiarity with safe operation and preparation for malfunction or conversion remain essential. Technical capabilities such as improved dexterity do not establish superior clinical outcomes for every procedure or patient population.
Apply it
A patient believes a robotic platform selects the operation and performs it autonomously. Explain that the surgeon directs instrument movement and makes clinical decisions. Discuss evidence for the particular proposed procedure, including expected benefits, complications and alternatives, rather than treating the platform's technical capabilities as proof of better outcomes.
Common pitfall: Do not apply the instrument-control mechanism of a robotically assisted device to every computer-assisted system: planning and navigation tools have different functions. Likewise, device availability does not establish patient suitability, and experience with conventional surgery does not replace training in the specific robotic system and procedure.
59.How should a claimed surgical innovation be evaluated?
A new surgical platform should be evaluated using outcomes relevant to the proposed procedure and patient group, including complications, recovery, functional results and oncological adequacy where applicable. Technical feasibility or regulatory marketing status alone does not prove superior clinical benefit. Consider the comparator, operator experience, follow-up and whether evidence applies to the intended use. The learning-curve context matters because performance in an experienced centre may not transfer unchanged to a newly adopting team or a different operation.
Apply it
A hospital proposes adopting a robotic technique because it permits precise instrument movement. Ask what comparative evidence shows about patient outcomes for that specific operation, and consider operator training and follow-up before concluding that technical capability equals clinical superiority.
Common pitfall: Extrapolating benefit from one procedure to all robotic operations ignores procedure-specific evidence. A short feasibility series may establish that an operation can be performed without establishing comparative effectiveness.
FDA: Computer-Assisted Surgical Systems · Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
60.When should difficult cholecystectomy use a bailout strategy?
If inflammation or fibrosis prevents safe identification of biliary anatomy, continuing dissection can create a major bile duct injury. The surgeon should pause, seek help or additional anatomical clarification where useful, and consider a bailout such as subtotal cholecystectomy when safe total removal is not achievable. The decision prioritises avoidance of misidentification injury. Conversion to open surgery may help in selected circumstances, but changing access does not automatically resolve an obscured anatomical problem or make further dissection safe.
Apply it
Dense inflammation prevents a safe critical view despite careful dissection. Explain the need to reassess, consider expert assistance and select a safer completion strategy, rather than persisting with total cholecystectomy solely to finish the planned operation.
Common pitfall: Persistence is not a safety strategy when anatomy remains uncertain. A bailout also carries complications, so its selection requires explicit judgement and postoperative planning rather than automatic substitution.
SAGES: Safe Cholecystectomy Multi-Society Practice Guideline
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give equal initial study attention to all four papers; the verified 25% weighting applies to paper marks, not individual diseases.
- For perioperative decisions, connect functional status and comorbidity to optimisation, transfusion, thromboprophylaxis and postoperative support.
- For emergency cases, identify the threatened organ, immediate physiological priorities, definitive intervention and findings that make delay unsafe.
- For elective abdominal cancer, connect tissue diagnosis and staging to resection, margin assessment and the sequence of multimodality treatment.
- Practise explaining investigation mechanisms and limitations, including thyroid ultrasound thresholds, architectural limits of cytology, vascular imaging and transplant compatibility testing.
- Write short notes that connect definitions, discriminating findings, investigation, management and complications rather than reproducing unprioritised lists.
- Develop practical discussion skills in clinical examination, image interpretation, operative anatomy, procedural safety and communication of uncertainty.
- Use the complete official knowledge and operative-skills schedules to extend beyond these selected concepts, including further gastrointestinal, orthopaedic, thoracic and other subspecialty topics.
A practical preparation plan
1. Map the complete curriculum
Build a four-paper topic map from the official curriculum's knowledge and operative-skills schedules. Mark each area as explain confidently, recognise but cannot justify, or needs first study. Include operative competencies and subspecialty exposure rather than relying on this selective guide as a complete syllabus.
2. Explain decisions aloud
For each concept, answer the heading before reading, then work through the mini-case. State the decisive cue, mechanism, next action and boundary that would change the decision. Use the pitfall to test whether your reasoning survives a plausible alternative.
3. Convert concepts into short notes
Write focused responses covering definition, relevant science, clinical discrimination, investigation and management. Practise timed short-note sets and check whether each response explains the decision criteria, alternatives and complications.
4. Use the learning questions diagnostically
Complete the 20 MCQs without consulting the guide. For each error, identify whether the problem was missing knowledge, misread clinical cues, incorrect prioritisation or an unsupported assumption. Explain why each alternative fails before repeating the item.
5. Rehearse practical reasoning
Discuss real or teaching cases with a supervisor: present findings, interpret investigations, justify treatment and describe operative hazards. Include perioperative risk, checklist communication, biopsy planning, elective cancer pathways, limb viability and emergency source control.
6. Revisit weak areas
Use spaced flashcard review alongside broader curriculum reading, returning more often to weak mechanisms and decision boundaries. Rework unfamiliar cases with changed clinical findings to test whether you can recognise when the appropriate management changes.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- NBEMS curriculum index
- Guidelines for Competency Based Training Programme in DNB General Surgery
- DNB Final Examination June 2026 Information Bulletin
- Surviving Sepsis Campaign Adult Guidelines 2026
- Implementation Manual: WHO Surgical Safety Checklist 2009
- Royal Children's Hospital Trauma Service: Head injury
- Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
- Cochrane Handbook, Chapter 8: Assessing risk of bias in a randomized trial
- NCI: Breast Cancer Treatment PDQ, Health Professional Version
- American Thyroid Association: Thyroid Nodules
- NCI: Pheochromocytoma and Paraganglioma Treatment PDQ
- NCI: Melanoma Treatment PDQ, Health Professional Version
- British Sarcoma Group: UK guidelines for the management of soft tissue sarcomas
- WSES Bologna guidelines for adhesive small bowel obstruction: 2017 update
- WSES: Acute mesenteric ischemia, updated guidelines 2022
- 2019 WSES guidelines for the management of severe acute pancreatitis
- 2017 WSES guidelines for emergency repair of complicated abdominal wall hernias
- 2024 AHA/ACC Lower Extremity Peripheral Artery Disease Guideline slide set
- EAU Guidelines on Urolithiasis: Limited Update March 2026
- Royal Children's Hospital: Pyloric stenosis
- NIDDK: Diagnosis of Hirschsprung Disease
- Royal Australasian College of Surgeons: Acute Scrotal Pain and Suspected Testicular Torsion, February 2018
- Royal Children's Hospital: Intussusception
- British Society for Immunology: Transplant Immunology
- FDA: Computer-Assisted Surgical Systems
- SAGES: Safe Cholecystectomy Multi-Society Practice Guideline
- NIH Office of Dietary Supplements: Vitamin C, Health Professional Fact Sheet
- NIH Office of Dietary Supplements: Vitamin K, Health Professional Fact Sheet
- American Academy of Orthopaedic Surgeons: Carpal Tunnel Syndrome
- AAO-HNSF Clinical Practice Guideline: Evaluation of the Neck Mass in Adults, 2017
- thy.2015.0020.pdf
- Client Challenge
- Acute scrotal pain and suspected testicular torsion guidelines (2022) | RACS
- KDIGO-2009-Transplant-Recipient-Guideline.pdf
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 | SCCM
- Trauma Service : Primary and secondary survey
- Recommendations | Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism | Guidance | NICE
- Colon Cancer Treatment (PDQ®) - NCI
- Management of Rectal Cancer (2020) | Evidence-based Guidelines and Expert Consensus
- JAMA_Carson_2023_AABB_RBC_Transfusion_Guidelines.pdf
- full-guideline-volume-1-pdf-4787002769
- Data Set for Pathology Reporting of Cutaneous Invasive Melanoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR) - PMC
- 2023_28-Neck-Mass-Evaluation.pdf
- Client Challenge
- Clinical Practice Guidelines : Pyloric stenosis
- Clinical Practice Guidelines : Intussusception
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.